FI925869A0 - FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL - Google Patents

FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL

Info

Publication number
FI925869A0
FI925869A0 FI925869A FI925869A FI925869A0 FI 925869 A0 FI925869 A0 FI 925869A0 FI 925869 A FI925869 A FI 925869A FI 925869 A FI925869 A FI 925869A FI 925869 A0 FI925869 A0 FI 925869A0
Authority
FI
Finland
Prior art keywords
peptid
cytosol
foerfarande foer
infoerande
foer infoerande
Prior art date
Application number
FI925869A
Other languages
Finnish (fi)
Other versions
FI925869A (en
Inventor
Sjur Olsnes
Original Assignee
Forskningsstiftelsen Det Norsk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskningsstiftelsen Det Norsk filed Critical Forskningsstiftelsen Det Norsk
Publication of FI925869A publication Critical patent/FI925869A/en
Publication of FI925869A0 publication Critical patent/FI925869A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI925869A 1990-06-27 1992-12-23 FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL FI925869A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
PCT/NO1991/000093 WO1992000099A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol

Publications (2)

Publication Number Publication Date
FI925869A FI925869A (en) 1992-12-23
FI925869A0 true FI925869A0 (en) 1992-12-23

Family

ID=19893304

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925869A FI925869A0 (en) 1990-06-27 1992-12-23 FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL

Country Status (8)

Country Link
EP (1) EP0542756A1 (en)
JP (1) JPH06503552A (en)
CA (1) CA2086342A1 (en)
FI (1) FI925869A0 (en)
HU (1) HUT63061A (en)
LT (1) LTIP835A (en)
NO (1) NO175188C (en)
WO (1) WO1992000099A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
US5935580A (en) * 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
DK0637335T3 (en) * 1992-04-21 2007-11-26 Pasteur Institut Recombinant mutants to induce specific immune responses
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US7422747B2 (en) 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US6777546B2 (en) 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
US6004815A (en) * 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
EP1254156A4 (en) * 2000-01-27 2003-05-21 Univ Loma Linda Transgenic plant-based vaccines
ATE438409T1 (en) 2000-09-15 2009-08-15 Pasteur Institut PROTEIN CONTAINING VECTORS FOR INTRODUCING MOLECULES INTO CD11B EXPRESSING CELLS
GB0524408D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US10988512B2 (en) * 2016-03-10 2021-04-27 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE25197T1 (en) * 1982-05-12 1987-02-15 Harvard College FUSIONED GENES ENCODING HYBRID PROTEIN, CLONING VECTORS CONTAINING THEM AND THEIR USE.
FR2532850B1 (en) * 1982-09-15 1985-12-20 Pasteur Institut IMMUNOGENIC CONJUGATES BETWEEN A HAPTENA AND A CARRIER MOLECULE DERIVED FROM A TOXIN, THE VACCINES CONTAINING THEM AND PROCESS FOR OBTAINING THEM
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
AU657087B2 (en) * 1989-12-22 1995-03-02 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region

Also Published As

Publication number Publication date
LTIP835A (en) 1995-02-27
NO175188C (en) 1994-09-14
NO175188B (en) 1994-06-06
NO902871D0 (en) 1990-06-27
FI925869A (en) 1992-12-23
AU653158B2 (en) 1994-09-22
WO1992000099A1 (en) 1992-01-09
EP0542756A1 (en) 1993-05-26
HUT63061A (en) 1993-07-28
CA2086342A1 (en) 1991-12-28
AU8000191A (en) 1992-01-23
JPH06503552A (en) 1994-04-21
HU9204125D0 (en) 1993-04-28
NO902871L (en) 1991-12-30

Similar Documents

Publication Publication Date Title
FI931357A (en) FRAMSTAELLNING AV POLYHYDROXIFETTSYRAAMIDER I NAERVARO AV LOESNINGSMEDEL
ATE190066T1 (en) NOVEL PEPTIDE DERIVATIVES
FI930886A0 (en) FOERFARANDE FOER HINDRANDE AV AVSTOETNING AV TRANSPLANTERAD VAEVNAD
FI930848A (en) FOERFARANDE FOER SEPARERING AV ILMENIT
FI930165A (en) FRAMSTAELLNING AV SYNNERLIGEN AKTIVA TVAETTMEDELSPARTIKLAR
FI934165A (en) FOERVAETSKNING AV GRANULAERA STAERKELSEUPPSLAMNINGAR UNDER ANVAENDNING AV ALFAAMYLAS I NAERVARO AV KARBONATJON
FI931355A (en) FASOEVERFOERINGSMEDIERAT FOERFARANDE FOER FRAMSTAELLNING AV GLUKAMIDTVAETTMEDEL
FI98406B (en) Nozzle
FI931356A (en) FOERBAETTRAT KATALYTISKT FOERFARANDE FOER FRAMSTAELLNING AV GLUKAMIDTVAETTMEDEL
FI925869A (en) FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL
FI925805A0 (en) FRAMSTAELLNING AV KOMPOSITMATERIAL
FI925609A (en) FOERFARANDE FOER FRAMSTAELLNING AV SYKLISKA SULFATER
FI923779A (en) FOERBAETTRINGAR I TILLVERKNINGEN AV NYLONGARN
FI930674A0 (en) THERAPEUTIC AEMNEN
FI925544A0 (en) BENSOESYRADERIVAT FOER BEHANDLING AV LEUKOTRIENASSOCIERADE SJUKDOMAR
FI930034A (en) FOERFARANDE FOER FRAMSTAELLNING AV AVLAONGT FOEREMAOL
FI931071A0 (en) THERAPEUTIC AEMNEN
KR920009092U (en) Drawaway tip
FI925546A (en) AMIDKOPPLADE PYRIDYLBENSOESYRADERIVAT FOER BEHANDLING AV LEUKOTRIEN-ASSOCIERADE SJUKDOMAR
FI930013A (en) HORMONDERIVAT AV BAKRE HYPOFYSLOBEN
FI924296A (en) RENGOERINGSPRODUKTER I VAETSKEFORM
FI930123A0 (en) FOERFARANDE FOER ANVAENDNING AV OXIDERADE LIPOPROTEINER I VIRUSARTADE INFEKTIONER
FI924154A (en) FOERFARANDE FOER FRAMSTAELLNING AV PENEM-ESTRAR
FI923795A (en) KRETSELEMENT FOER AOSTADKOMMANDE AV EN SPAERRSPAENNING FOER KOPPLINSDIODER
DK262590D0 (en) atomizer